Literature DB >> 20705736

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.

Thomas M Wishart1, Jack P-W Huang, Lyndsay M Murray, Douglas J Lamont, Chantal A Mutsaers, Jenny Ross, Pascal Geldsetzer, Olaf Ansorge, Kevin Talbot, Simon H Parson, Thomas H Gillingwater.   

Abstract

Reduced expression of the survival motor neuron (SMN) gene causes the childhood motor neuron disease spinal muscular atrophy (SMA). Low levels of ubiquitously expressed SMN protein result in the degeneration of lower motor neurons, but it remains unclear whether other regions of the nervous system are also affected. Here we show that reduced levels of SMN lead to impaired perinatal brain development in a mouse model of severe SMA. Regionally selective changes in brain morphology were apparent in areas normally associated with higher SMN levels in the healthy postnatal brain, including the hippocampus, and were associated with decreased cell density, reduced cell proliferation and impaired hippocampal neurogenesis. A comparative proteomics analysis of the hippocampus from SMA and wild-type littermate mice revealed widespread modifications in expression levels of proteins regulating cellular proliferation, migration and development when SMN levels were reduced. This study reveals novel roles for SMN protein in brain development and maintenance and provides the first insights into cellular and molecular pathways disrupted in the brain in a severe form of SMA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705736      PMCID: PMC2951867          DOI: 10.1093/hmg/ddq340

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.

Authors:  S Jablonka; B Schrank; M Kralewski; W Rossoll; M Sendtner
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Increased hippocampal neurogenesis in Alzheimer's disease.

Authors:  Kunlin Jin; Alyson L Peel; Xiao Ou Mao; Lin Xie; Barbara A Cottrell; David C Henshall; David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

3.  Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus.

Authors:  H A Cameron; R D McKay
Journal:  J Comp Neurol       Date:  2001-07-09       Impact factor: 3.215

4.  A neuropathologic study of Werdnig-Hoffmann disease with special reference to the thalamus and posterior roots.

Authors:  K Shishikura; M Hara; Y Sasaki; K Misugi
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 5.  Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.

Authors:  L M Murray; K Talbot; T H Gillingwater
Journal:  Neuropathol Appl Neurobiol       Date:  2010-02-19       Impact factor: 8.090

6.  [Genetically confirmed spinal muscular atrophy type III with epilepsy, cerebral hypoperfusion, and parahippocampal gyrus atrophy].

Authors:  K Higashi; M Nakagawa; I Higuchi; K Saito; M Osame
Journal:  Rinsho Shinkeigaku       Date:  2000-04

7.  Progressive and selective degeneration of motoneurons in a mouse model of SMA.

Authors:  A Ferri; J Melki; A C Kato
Journal:  Neuroreport       Date:  2004-02-09       Impact factor: 1.837

8.  Thalamic lesions in a long-surviving child with spinal muscular atrophy type I: MRI and EEG findings.

Authors:  Yasushi Ito; Satoko Kumada; Akira Uchiyama; Kayoko Saito; Makiko Osawa; Akira Yagishita; Kiyoko Kurata; Masaharu Hayashi
Journal:  Brain Dev       Date:  2004-01       Impact factor: 1.961

9.  Neuropathological analysis in spinal muscular atrophy type II.

Authors:  S Araki; M Hayashi; K Tamagawa; M Saito; S Kato; T Komori; Y Sakakihara; T Mizutani; M Oda
Journal:  Acta Neuropathol       Date:  2003-07-25       Impact factor: 17.088

10.  Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy.

Authors:  S Rudnik-Schöneborn; H H Goebel; W Schlote; S Molaian; H Omran; U Ketelsen; R Korinthenberg; D Wenzel; H Lauffer; M Kreiss-Nachtsheim; B Wirth; K Zerres
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

View more
  51 in total

1.  Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction.

Authors:  Rocky G Gogliotti; Katharina A Quinlan; Courtenay B Barlow; Christopher R Heier; C J Heckman; Christine J Didonato
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

2.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

3.  Single-Cell Analysis of SMN Reveals Its Broader Role in Neuromuscular Disease.

Authors:  Natalia Rodriguez-Muela; Nadia K Litterman; Erika M Norabuena; Jesse L Mull; Maria José Galazo; Chicheng Sun; Shi-Yan Ng; Nina R Makhortova; Andrew White; Maureen M Lynes; Wendy K Chung; Lance S Davidow; Jeffrey D Macklis; Lee L Rubin
Journal:  Cell Rep       Date:  2017-02-07       Impact factor: 9.423

4.  SMN is essential for the biogenesis of U7 small nuclear ribonucleoprotein and 3'-end formation of histone mRNAs.

Authors:  Sarah Tisdale; Francesco Lotti; Luciano Saieva; James P Van Meerbeke; Thomas O Crawford; Charlotte J Sumner; George Z Mentis; Livio Pellizzoni
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

Review 5.  Mouse models of SMA: tools for disease characterization and therapeutic development.

Authors:  Thomas W Bebee; Catherine E Dominguez; Dawn S Chandler
Journal:  Hum Genet       Date:  2012-04-29       Impact factor: 4.132

6.  Temporal requirement for SMN in motoneuron development.

Authors:  Le T Hao; Phan Q Duy; James D Jontes; Marc Wolman; Michael Granato; Christine E Beattie
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

7.  Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose.

Authors:  Ann K Wright; Thomas M Wishart; Cali A Ingham; Thomas H Gillingwater
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 8.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

9.  The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models.

Authors:  Rocky G Gogliotti; Herminio Cardona; Jasbir Singh; Sophie Bail; Carina Emery; Nancy Kuntz; Michael Jorgensen; Madel Durens; Bing Xia; Courtenay Barlow; Christopher R Heier; Heather L Plasterer; Vincent Jacques; Megerditch Kiledjian; Jill Jarecki; James Rusche; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

10.  Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy.

Authors:  Thomas M Wishart; Chantal A Mutsaers; Markus Riessland; Michell M Reimer; Gillian Hunter; Marie L Hannam; Samantha L Eaton; Heidi R Fuller; Sarah L Roche; Eilidh Somers; Robert Morse; Philip J Young; Douglas J Lamont; Matthias Hammerschmidt; Anagha Joshi; Peter Hohenstein; Glenn E Morris; Simon H Parson; Paul A Skehel; Thomas Becker; Iain M Robinson; Catherina G Becker; Brunhilde Wirth; Thomas H Gillingwater
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.